Merck partners with Moderna to test KRas cancer vaccines in humans
Wednesday, July 25, 2018 - 14:58
in Health & Medicine
The pair hopes to stimulate the immune system to tackle tumors bearing mutant KRas proteins, one of cancer’s toughest targets